October 21, 2019
Carisma's VP of Business Development, Dora Mitchell, PhD and VP of Discovery Research, Michael Klichinsky, PharmD, PhD chaired and presented at the inaugural macrophage-directed therapies summit taking place October 22-24, 2019 in Boston, MA.
October 7, 2019
Carisma Therapeutics will present at the Chardan 3rd Annual Genetic Medicines Conference being held October 7-8, 2019, at the Westin New York Grand Central in New York City.
October 1, 2019
Carisma Therapeutics will present at the annual Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Mesa in Carlsbad, CA, October 2-4, 2019.
September 25, 2019
Michael Klichinsky, VP of Discovery, delivers the Featured Presentation at the inaugural Targeting Innate Immunity Congress: Differentiating Friends from Foes held in Boston, MA, September 24-25, 2019.
September 9, 2019
"Metastatic solid tumors have been an intractable challenge for engineered cell therapies. Our platform technology, based on the genetically engineered macrophage, has a unique opportunity to provide benefit in this disease state," said Dr. Michael Klichinsky, co-Founder and Vice President of Discovery at Carisma.
September 3, 2019
Michael Klichinsky, co-founder and VP of Discovery, to discuss why Carisma's CAR Macrophages are tailor-made for solid tumor immunotherapy on Friday, September 13 at 12, noon, at the Seaport World Trade Center in Boston.